5,171
Views
58
CrossRef citations to date
0
Altmetric
Original Articles

Safety of radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: a systematic review and meta-analysis

, , ORCID Icon, , &
Pages 920-930 | Received 03 Apr 2017, Accepted 30 May 2017, Published online: 26 Jun 2017

References

  • Choi H, Loyer EM, DuBrow RA, et al. (2001). Radio-frequency ablation of liver tumors: assessment of therapeutic response and complications. Radiographics 21:S41–54.
  • Dupuy DE, Goldberg SN. (2001). Image-guided radiofrequency tumor ablation: challenges and opportunities – part II. J Vasc Interv Radiol 12:1135–48.
  • Lencioni R, Cioni D, Bartolozzi C. (2001). Percutaneous radiofrequency thermal ablation of liver malignancies: techniques, indications, imaging findings, and clinical results. Abdom Imaging 26:345–60.
  • Livraghi T, Solbiati L, Meloni MF, et al. (2003). Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 226:441–51.
  • Bernardi S, Dobrinja C, Fabris B, et al. (2014). Radiofrequency ablation compared to surgery for the treatment of benign thyroid nodules. Int J Endocrinol 2014:934595.
  • Huh JY, Baek JH, Choi H, et al. (2012). Symptomatic benign thyroid nodules: efficacy of additional radiofrequency ablation treatment session – prospective randomized study. Radiology 263:909–16.
  • Kim YS, Rhim H, Tae K, et al. (2006). Radiofrequency ablation of benign cold thyroid nodules: initial clinical experience. Thyroid 16:361–7.
  • Spiezia S, Garberoglio R, Milone F, et al. (2009). Thyroid nodules and related symptoms are stably controlled two years after radiofrequency thermal ablation. Thyroid 19:219–25.
  • Russ G. (2016). Risk stratification of thyroid nodules on ultrasonography with the French TI-RADS: description and reflections. Ultrasonography 35:25–38.
  • Shin JH, Baek JH, Chung J, et al. (2016). Ultrasonography diagnosis and imaging-based management of thyroid nodules: revised Korean Society of Thyroid Radiology Consensus Statement and Recommendations. Korean J Radiol 17:370–95.
  • Sung JY, Baek JH, Jung SL, et al. (2015). Radiofrequency ablation for autonomously functioning thyroid nodules: a multicenter study. Thyroid 25:112–17.
  • Ugurlu MU, Uprak K, Akpinar IN, et al. (2015). Radiofrequency ablation of benign symptomatic thyroid nodules: prospective safety and efficacy study. World J Surg 39:961–8.
  • Faggiano A, Ramundo V, Assanti AP, et al. (2012). Thyroid nodules treated with percutaneous radiofrequency thermal ablation: a comparative study. J Clin Endocrinol Metab 97:4439–45.
  • Che Y, Jin S, Shi C, et al. (2015). Treatment of benign thyroid nodules: comparison of surgery with radiofrequency ablation. Am J Neuroradiol 36:1321–5.
  • Deandrea M, Sung JY, Limone P, et al. (2015). Efficacy and safety of radiofrequency ablation versus observation for nonfunctioning benign thyroid nodules: a randomized controlled international collaborative trial. Thyroid 25:890–6.
  • Suh CH, Baek JH, Choi YJ, Lee JH. (2016). Efficacy and safety of radiofrequency and ethanol ablation for treating locally recurrent thyroid cancer: a systematic review and meta-analysis. Thyroid 26:420–8.
  • Baek JH, Kim YS, Sung JY, et al. (2011). Locoregional control of metastatic well-differentiated thyroid cancer by ultrasound-guided radiofrequency ablation. Am J Roentgenol 197:W331–6.
  • Guenette JP, Monchik JM, Dupuy DE. (2013). Image-guided ablation of postsurgical locoregional recurrence of biopsy-proven well-differentiated thyroid carcinoma. J Vasc Interv Radiol 24:672–9.
  • Kim JH, Yoo WS, Park YJ, et al. (2015). Efficacy and safety of radiofrequency ablation for treatment of locally recurrent thyroid cancers smaller than 2 cm. Radiology 276:909–18.
  • Lee SJ, Jung SL, Kim BS, et al. (2014). Radiofrequency ablation to treat loco-regional recurrence of well-differentiated thyroid carcinoma. Korean J Radiol 15:817–26.
  • Wang L, Ge M, Xu D, et al. (2014). Ultrasonography-guided percutaneous radiofrequency ablation for cervical lymph node metastasis from thyroid carcinoma. J Cancer Res Ther 10:C144–9.
  • Haugen BR, Alexander EK, Bible KC, et al. (2016). 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid 26:1–133.
  • Aysan E, Idiz UO, Akbulut H, Elmas L. (2016). Single-session radiofrequency ablation on benign thyroid nodules: a prospective single center study: radiofrequency ablation on thyroid. Langenbecks Arch Surg 401:357–63.
  • Baek JH, Lee JH, Sung JY, et al. (2012). Complications encountered in the treatment of benign thyroid nodules with US-guided radiofrequency ablation: a multicenter study. Radiology 262:335–42.
  • Cesareo R, Pasqualini V, Simeoni C, et al. (2015). Prospective study of effectiveness of ultrasound-guided radiofrequency ablation versus control group in patients affected by benign thyroid nodules. J Clin Endocrinol Metab 100:460–6.
  • Lim HK, Baek JH, Lee JH, et al. (2015). Efficacy and safety of radiofrequency ablation for treating locoregional recurrence from papillary thyroid cancer. Eur Radiol 25:163–70.
  • Xu D, Wang L, Long B, et al. (2016). Radiofrequency ablation for postsurgical thyroid removal of differentiated thyroid carcinoma. Am J Transl Res 8:1876–85.
  • Burke DR, Lewis CA, Cardella JF, et al. (2003). Quality improvement guidelines for percutaneous transhepatic cholangiography and biliary drainage. J Vasc Interv Radiol 14:S243–6.
  • Lewis CA, Allen TE, Burke DR, et al. (1997). Quality improvement guidelines for central venous access. The Standards of Practice Committee of the Society of Cardiovascular & Interventional Radiology. J Vasc Interv Radiol 8:475–9.
  • Whiting PF, Rutjes AW, Westwood ME, et al. (2011). QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529–36.
  • Suh CH, Park SH. (2016). Successful publication of systematic review and meta-analysis of studies evaluating diagnostic test accuracy. Korean J Radiol 17:5–6.
  • Lee J, Kim KW, Choi SH, et al. (2015). Systematic review and meta-analysis of studies evaluating diagnostic test accuracy: a practical review for clinical researchers-part II. Statistical methods of meta-analysis. Korean J Radiol 16:1188–96.
  • Kim KW, Lee J, Choi SH, et al. (2015). Systematic review and meta-analysis of studies evaluating diagnostic test accuracy: a practical review for clinical researchers-Part I. General guidance and tips. Korean J Radiol 16:1175–87.
  • Higgins J, Green S. (2011). Cochrane handbook for systematic reviews of interventions. Version 5.1.0. The Cochrane Collaboration. Available from: http://handbook.cochrane.org
  • Egger M, Davey Smith G, Schneider M, Minder C. (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–34.
  • Dupuy DE, Monchik JM, Decrea C, Pisharodi L. (2001). Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy. Surgery 130:971–7.
  • Monchik JM, Donatini G, Iannuccilli J, Dupuy DE. (2006). Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma. Ann Surg 244:296–304.
  • Jeong WK, Baek JH, Rhim H, et al. (2008). Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur Radiol 18:1244–50.
  • Baek JH, Moon WJ, Kim YS, et al. (2009). Radiofrequency ablation for the treatment of autonomously functioning thyroid nodules. World J Surg 33:1971–7.
  • Baek JH, Kim YS, Lee D, et al. (2010). Benign predominantly solid thyroid nodules: prospective study of efficacy of sonographically guided radiofrequency ablation versus control condition. Am J Roentgenol 194:1137–42.
  • Shin JH, Jung SL, Baek JH, Kim JH. (2011). Rupture of benign thyroid tumors after radio-frequency ablation. Am J Neuroradiol 32:2165–9.
  • Sung JY, Kim YS, Choi H, et al. (2011). Optimum first-line treatment technique for benign cystic thyroid nodules: ethanol ablation or radiofrequency ablation? Am J Roentgenol 196:W210–4.
  • Nakamura S, Nouso K, Kobayashi Y, et al. (2013). The diagnosis of hypovascular hepatic lesions showing hypo-intensity in the hepatobiliary phase of Gd-EOB-DTPA-enhanced MR imaging in high-risk patients for hepatocellular carcinoma. Acta Med Okayama 67:239–44.
  • Lim HK, Lee JH, Ha EJ, et al. (2013). Radiofrequency ablation of benign non-functioning thyroid nodules: 4-year follow-up results for 111 patients. Eur Radiol 23:1044–9.
  • Ji Hong M, Baek JH, Choi YJ, et al. (2015). Radiofrequency ablation is a thyroid function-preserving treatment for patients with bilateral benign thyroid nodules. J Vasc Interv Radiol 26:55–61.
  • Lee JH, Kim YS, Lee D, et al. (2010). Radiofrequency ablation (RFA) of benign thyroid nodules in patients with incompletely resolved clinical problems after ethanol ablation (EA). World J Surg 34:1488–93.
  • Jang SW, Baek JH, Kim JK, et al. (2012). How to manage the patients with unsatisfactory results after ethanol ablation for thyroid nodules: role of radiofrequency ablation. Eur J Radiol 81:905–10.
  • Kim DW. (2012). Sonography-guided ethanol ablation of a remnant solid component after radio-frequency ablation of benign solid thyroid nodules: a preliminary study. Am J Neuroradiol 33:1139–43.
  • Yoon HM, Baek JH, Lee JH, et al. (2014). Combination therapy consisting of ethanol and radiofrequency ablation for predominantly cystic thyroid nodules. Am J Neuroradiol 35:582–6.
  • Long B, Li L, Yao L, et al. (2015). Combined use of radioiodine therapy and radiofrequency ablation in treating postsurgical thyroid remnant of differentiated thyroid carcinoma. J Cancer Res Ther 11:244. Suppl:C7.
  • Deandrea M, Limone P, Basso E, et al. (2008). US-guided percutaneous radiofrequency thermal ablation for the treatment of solid benign hyperfunctioning or compressive thyroid nodules. Ultrasound Med Biol 34:784–91.
  • Park KW, Shin JH, Han BK, et al. (2011). Inoperable symptomatic recurrent thyroid cancers: preliminary result of radiofrequency ablation. Ann Surg Oncol 18:2564–8.
  • Sung JY, Baek JH, Kim KS, et al. (2013). Single-session treatment of benign cystic thyroid nodules with ethanol versus radiofrequency ablation: a prospective randomized study. Radiology 269:293–300.
  • Suh CH, Kim SY, Kim KW, et al. (2014). Determination of normal hepatic elasticity by using real-time shear-wave elastography. Radiology 271:895–900.
  • Turtulici G, Orlandi D, Corazza A, et al. (2014). Percutaneous radiofrequency ablation of benign thyroid nodules assisted by a virtual needle tracking system. Ultrasound Med Biol 40:1447–52.
  • Baek JH, Ha EJ, Choi YJ, et al. (2015). Radiofrequency versus ethanol ablation for treating predominantly cystic thyroid nodules: a randomized clinical trial. Korean J Radiol 16:1332–40.
  • Kohlhase KD, Korkusuz Y, Groner D, et al. (2016). Bipolar radiofrequency ablation of benign thyroid nodules using a multiple overlapping shot technique in a 3-month follow-up. Int J Hyperthermia 32:511–16.
  • Li XL, Xu HX, Lu F, et al. (2016). Treatment efficacy and safety of ultrasound-guided percutaneous bipolar radiofrequency ablation for benign thyroid nodules. Br J Radiol 89:20150858.
  • Ha EJ, Baek JH, Lee JH. (2014). Moving-shot versus fixed electrode techniques for radiofrequency ablation: comparison in an ex-vivo bovine liver tissue model. Korean J Radiol 15:836–43.
  • Shin JH, Baek JH, Ha EJ, Lee JH. (2012). Radiofrequency ablation of thyroid nodules: basic principles and clinical application. Int J Endocrinol 2012:919650.
  • Ha EJ, Baek JH, Lee JH. (2015). Ultrasonography-based thyroidal and perithyroidal anatomy and its clinical significance. Korean J Radiol 16:749–66.
  • Pacella CM, Mauri G, Achille G, et al. (2015). Outcomes and risk factors for complications of laser ablation for thyroid nodules: a multicenter study on 1531 patients. J Clin Endocrinol Metab 100:3903–10.
  • Ha EJ, Baek JH, Kim KW, et al. (2015). Comparative efficacy of radiofrequency and laser ablation for the treatment of benign thyroid nodules: systematic review including traditional pooling and bayesian network meta-analysis. J Clin Endocrinol Metab 100:1903–11.
  • Mauri G, Cova L, Monaco CG, et al. (2017). Benign thyroid nodules treatment using percutaneous laser ablation (PLA) and radiofrequency ablation (RFA). Int J Hyperthermia 33:295–9.
  • Mauri G, Cova L, Tondolo T, et al. (2013). Percutaneous laser ablation of metastatic lymph nodes in the neck from papillary thyroid carcinoma: preliminary results. J Clin Endocrinol Metab 98:E1203–7.
  • Papini E, Bizzarri G, Bianchini A, et al. (2013). Percutaneous ultrasound-guided laser ablation is effective for treating selected nodal metastases in papillary thyroid cancer. J Clin Endocrinol Metab 98:E92–7.
  • Mauri G, Cova L, Ierace T, et al. (2016). Treatment of metastatic lymph nodes in the neck from papillary thyroid carcinoma with percutaneous laser ablation. Cardiovasc Intervent Radiol 39:1023–30.
  • Kim DW. (2014). Usefulness of two-stage ethanol ablation in the treatment of benign predominantly cystic thyroid nodules. Endocr Pract 20:548–55.
  • Lee SJ, Ahn IM. (2005). Effectiveness of percutaneous ethanol injection therapy in benign nodular and cystic thyroid diseases: long-term follow-up experience. Endocr J 52:455–62.
  • Kim DW, Rho MH, Park HJ, Kwag HJ. (2012). Ultrasonography-guided ethanol ablation of predominantly solid thyroid nodules: a preliminary study for factors that predict the outcome. Br J Radiol 85:930–6.
  • Cho YS, Lee HK, Ahn IM, et al. (2000). Sonographically guided ethanol sclerotherapy for benign thyroid cysts: results in 22 patients. Am J Roentgenol 174:213–16.
  • Heilo A, Sigstad E, Fagerlid KH, et al. (2011). Efficacy of ultrasound-guided percutaneous ethanol injection treatment in patients with a limited number of metastatic cervical lymph nodes from papillary thyroid carcinoma. J Clin Endocrinol Metab 96:2750–5.
  • Kim JH, Lee HK, Lee JH, et al. (2003). Efficacy of sonographically guided percutaneous ethanol injection for treatment of thyroid cysts versus solid thyroid nodules. Am J Roentgenol 180:1723–6.
  • Basu N, Dutta D, Maisnam I, et al. (2014). Percutaneous ethanol ablation in managing predominantly cystic thyroid nodules: an eastern India perspective. Indian J Endocrinol Metab 18:662–8.
  • Hay ID, Lee RA, Davidge-Pitts C, et al. (2013). Long-term outcome of ultrasound-guided percutaneous ethanol ablation of selected “recurrent” neck nodal metastases in 25 patients with TNM stages III or IVA papillary thyroid carcinoma previously treated by surgery and 131I therapy. Surgery 154:1448–54. discussion 54-5.
  • Kim BM, Kim MJ, Kim E-K, et al. (2008). Controlling recurrent papillary thyroid carcinoma in the neck by ultrasonography-guided percutaneous ethanol injection. Eur Radiol 18:835–42.
  • Lim CY, Yun JS, Lee J, et al. (2007). Percutaneous ethanol injection therapy for locally recurrent papillary thyroid carcinoma. Thyroid 17:347–50.
  • Lewis BD, Hay ID, Charboneau JW, et al. (2002). Percutaneous ethanol injection for treatment of cervical lymph node metastases in patients with papillary thyroid carcinoma. Am J Roentgenol 178:699–704.
  • Lang BH, Wong CK, Tsang JS, et al. (2014). A systematic review and meta-analysis comparing surgically-related complications between robotic-assisted thyroidectomy and conventional open thyroidectomy. Ann Surg Oncol 21:850–61.
  • Padur AA, Kumar N, Guru A, et al. (2016). Safety and effectiveness of total thyroidectomy and its comparison with subtotal thyroidectomy and other thyroid surgeries: a systematic review. J Thyroid Res 2016:7594615.
  • Kim MK, Mandel SH, Baloch Z, et al. (2004). Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer. Arch Otolaryngol Head Neck Surg 130:1214–16.
  • Al-Saif O, Farrar WB, Bloomston M, et al. (2010). Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer. J Clin Endocrinol Metab 95:2187–94.
  • Shin JE, Baek JH, Lee JH. (2013). Radiofrequency and ethanol ablation for the treatment of recurrent thyroid cancers: current status and challenges. Curr Opin Oncol 25:14–19.
  • Pishdad GR, Pishdad P, Pishdad R. (2011). Horner’s syndrome as a complication of percutaneous ethanol treatment of thyroid nodule. Thyroid 21:327–8.
  • Bartos M, Pomorski L, Narebski J. (1999). The treatment of solitary thyroid nodules in non-toxic goiter with 96% ethanol injections. Wiad Lek 52:432–40.
  • Shin JE, Baek JH, Ha EJ, et al. (2015). Ultrasound features of middle cervical sympathetic ganglion. Clin J Pain 31:909–13.
  • Hong MJ, Baek JH, Kim DY, et al. (2016). Spinal accessory nerve: ultrasound findings and correlations with neck lymph node levels. Ultraschall Med 37:487–91.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.